Nigeria: Malaria Kills 81,640, Infects 53.7 Million Yearly
[Guardian] Efforts by government at all levels and the international community notwithstanding, malaria still kills no fewer than 81,640 Nigerians and infects 53.7 million yearly.
A 25 year-old tuberculosis patient is treated at her home in Funafuti, the main island of Tuvalu in the South Pacific. Credit: UNDP Tuvalu/Aurélia Rusek.By External SourceUNITED NATIONS, Oct 17 2019 (IPS) A staggering 1.5 million people died from tuberculosis (TB) last year, the UN health agency said on Thursday, in an appeal for far greater funding and political support to eradicate the curable and preventable disease. Caused by the bacteria Mycobacterium tuberculosis, TB commonly causes persistent coughing, fatigue and weight loss. According to the World Health Organization (WHO) and its latest Global TB Report, a...
Condition: Malaria,Falciparum Intervention: Biological: Pfs25-IMX313/Matrix-M1 Sponsor: University of Oxford Recruiting
Scientists have rediscovered a compound developed by German researchers during World War II. It appears to be more effective and perhaps safer than DDT.
Authors: Szuster-Ciesielska A, Wawiórka L, Krokowski D, Grankowski N, Jarosz Ł, Lisiecka U, Tchórzewski M Abstract Malaria remains one the most infectious and destructive protozoan diseases worldwide. Plasmodium falciparum, a protozoan parasite with a complex life cycle and high genetic variability responsible for the difficulties in vaccine development, is implicated in most malaria-related deaths. In the course of study, we prepared a set of antigens based on P-proteins from P. falciparum and determined their immunogenicity in an in vivo assay on a mouse model. The pentameric complex P0-(P1-P2)2 wa...
[This Day] Abuja -Thirteen states of the federation, including Kaduna, Kano, Katsina, Jigawa, Kwara, Niger, Taraba, Gombe, Yobe, Adamawa, Ogun, Osun and Delta states are currently benefiting from the health and peace initiative supported by the Global Fund (GF).
Plasmodium falciparum drug resistance surveillance is key to successful disease control and eradication. Contemporary methods that only allow determination of prevalence of resistance are expensive, time consumin...
ConclusionsThe study findings suggest that clinical interventions aimed at enhancing the safety and tolerance of quinine might be achieved by a rational decrease in dose size and/or dosing interval, post-48 hours of chronic quinine administration, in malaria-infected patients.
Date: Tuesday, 10 22, 2019; Speaker: Raymond John St. Leger, Professor, Entomology Departmetn, University of Maryland; 5625 Fishers Lane; 5th Floor Conference Room
Date: Tuesday, 10 29, 2019; Speaker: Manoj Duraisingh, Professor, Harvard T. H. Chan School of Public Health; 5625 Fishers Lane; 5th Floor Conference Room